212 related articles for article (PubMed ID: 24945407)
1. A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.
Savkovic B; Nichols J; Birkett D; Applegate T; Ledger S; Symonds G; Murray JM
PLoS Comput Biol; 2014 Jun; 10(6):e1003681. PubMed ID: 24945407
[TBL] [Abstract][Full Text] [Related]
2. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
Tsukamoto T
AIDS; 2018 Aug; 32(13):1737-1747. PubMed ID: 29762163
[TBL] [Abstract][Full Text] [Related]
4. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.
Petit NY; Baillou C; Burlion A; Dorgham K; Levacher B; Amiel C; Schneider V; Lemoine FM; Gorochov G; Marodon G
Gene Ther; 2016 Feb; 23(2):144-50. PubMed ID: 26488891
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV.
Murray JM; Fanning GC; Macpherson JL; Evans LA; Pond SM; Symonds GP
J Gene Med; 2009 Dec; 11(12):1077-86. PubMed ID: 19777528
[TBL] [Abstract][Full Text] [Related]
7. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.
Peterson CW; Younan P; Jerome KR; Kiem HP
Gene Ther; 2013 Jul; 20(7):695-702. PubMed ID: 23364313
[TBL] [Abstract][Full Text] [Related]
9. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
[TBL] [Abstract][Full Text] [Related]
10. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
[TBL] [Abstract][Full Text] [Related]
11. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
12. CCR5 as a natural and modulated target for inhibition of HIV.
Burke BP; Boyd MP; Impey H; Breton LR; Bartlett JS; Symonds GP; Hütter G
Viruses; 2013 Dec; 6(1):54-68. PubMed ID: 24381033
[TBL] [Abstract][Full Text] [Related]
13. HIV Impacts CD34
Tsukamoto T
Front Immunol; 2019; 10():81. PubMed ID: 30761146
[TBL] [Abstract][Full Text] [Related]
14. Persistence and emergence of X4 virus in HIV infection.
Weinberger AD; Perelson AS
Math Biosci Eng; 2011 Apr; 8(2):605-26. PubMed ID: 21631149
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
[TBL] [Abstract][Full Text] [Related]
16. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
[TBL] [Abstract][Full Text] [Related]
17. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
18. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
19. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
Bai J; Rossi J; Akkina R
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
[TBL] [Abstract][Full Text] [Related]
20. A mathematical model of HIV dynamics treated with a population of gene-edited haematopoietic progenitor cells exhibiting threshold phenomenon.
Ratti V; Nanda S; Eszterhas SK; Howell AL; Wallace DI
Math Med Biol; 2020 May; 37(2):212-242. PubMed ID: 31265056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]